Financhill
Back

Cue Biopharma Vs. Arbutus Biopharma Industry Stock Comparison

Sell
28

CUE
Cue Biopharma

Last Price:
1.23
Seasonality Move:
14.02%
Sell
37

ABUS
Arbutus Biopharma

Last Price:
3.47
Seasonality Move:
24.22%
Sell
28
Cue Biopharma (CUE) is a Sell

Is Cue Biopharma a Buy, Sell or Hold?

  • The current Cue Biopharma [CUE] share price is $1.09. The Score for CUE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • CUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.41. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CUE Stock Price Chart

What is Cue Biopharma's stock price today?

  • The Cue Biopharma share price today is $1.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing slight buying pressure.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight selling pressure.

CUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 40.82 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.18 - 1.74) Sell
Bollinger Bands (100): (0.57 - 1.35) Buy

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 30.86 Sell
Chaikin Money Flow: -303520 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.53 - 3.97) Sell
Bollinger Bands (100): (3.59 - 4.11) Sell

CUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.09 Buy
20-day SMA: 1.42 Sell
50-day SMA: 1.2 Sell
200-day SMA: 1.36 Sell
8-day EMA: 1.15 Sell
20-day EMA: 1.29 Sell
50-day EMA: 1.23 Sell
200-day EMA: 1.44 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.49 Sell
20-day SMA: 3.68 Sell
50-day SMA: 3.85 Sell
200-day SMA: 3.39 Buy
8-day EMA: 3.5 Sell
20-day EMA: 3.64 Sell
50-day EMA: 3.77 Sell
200-day EMA: 3.43 Sell

Cue Biopharma Earnings Growth & CUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Cue Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):